The presence of lipids in the small intestine potently suppresses food intake; however, whether 5-HT 3 receptors play a role in this response has not been directly examined. Therefore, using the selective 5-HT3 receptor antagonist ondansetron, we tested the hypothesis that duodenal infusion of lipid suppresses intake of both sucrose solution and chow through 5-HT3 receptor activation. Rats duodenally infused with 72 and 130 mM Intralipid suppressed 1-h 15% sucrose intake by 33 and 67%, respectively. Suppression of sucrose intake by 72 mM Intralipid was significantly attenuated by ondansetron at all doses tested (0.5, 1.0, 2.0, and 5.0 mg/kg ip), whereas the lowest effective dose of ondansetron to attenuate suppression of intake by 130 mM Intralipid was 1.0 mg/kg. Furthermore, infusion of 130 mM Intralipid suppressed 1-and 4-h chow intake by 35 and 20%, respectively. Ondansetron administered as low as 0.5 mg/kg significantly attenuated 1-h Intralipid-induced suppression of chow intake and completely reversed the suppression by 4 h. Administration of ondansetron alone did not alter sucrose or chow intake compared with vehicle injection at any time. Finally, to test whether Intralipidinduced neuronal activation of the dorsal vagal complex is mediated by 5-HT 3 receptors, Fos-like immunoreactivity (Fos-LI) was quantified in ondansetron-pretreated rats following intestinal lipid infusion. Ondansetron (1 mg/kg) significantly attenuated duodenal intralipidinduced Fos-LI in the dorsal hindbrain. These data support the hypothesis that 5-HT3 receptors mediate both satiation, as well as hindbrain neuronal responses evoked by intestinal lipids. food intake; lipids; intestinal chemoreception IT IS WELL ESTABLISHED THAT nutrients within the duodenal lumen early in a meal play an essential role in producing satiation that occurs with meal ingestion. This is supported by evidence that duodenal infusion of lipids reduce sham food intake (20), whereas intravenous infusion of lipids does not (21), demonstrating that the satiating effect of intraduodenal lipids occurs largely before absorbed lipids enter the blood (19). The predominant hypothesis is that paracrine or endocrine products of intestinal origin, secreted in response to intestinal nutrients, activate vagal afferent fibers leading to inhibition of food intake (11,16,42). The indoleamine serotonin (5-HT) is one such signal. Over 95% of the body's 5-HT is located in the gut, with at least 90% present in enterochromaffin (EC) cells that are scattered in the enteric epithelium from the stomach through the colon (15, 17). The abundance of 5-HT in the gut has made this neuromodulator the focus of numerous studies investigating regulatory feedback mechanisms of food intake.Systemic serotonergic activity regulates gastrointestinal functions through activation of a number of receptors, including the excitatory, ligand-gated cation channel 5-HT type-3 (5-HT 3 ) receptor. This receptor type is predominantly located on terminals of vagal afferent fibers (8,18,43) and is also found wi...